Snowball logo
logo
IDXX_logo

IDEXX LABORATORIES INC ORDSHS

₽4,010.00-₽740.00  (15.58%)
Estimate
P/E
0.6
EPS
1,034.184
Beta
0.307
Growth
Revenue, YoY
10.36%
Net income, YoY
15.85%
FCF, YoY
114.04%
Forecast
P/E (FWD)
40.1
EPS (FWD)
16.733
About the company
Ticker
IDXX-RM
ISIN
US45168D1046
Country
Other
Sector (GICS)
Healthcare
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Frequently asked questions

What sector does IDEXX LABORATORIES INC ORDSHS (IDXX-RM) operate in?

IDEXX LABORATORIES INC ORDSHS belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is IDEXX LABORATORIES INC ORDSHS (IDXX-RM) current stock price?

As of the latest data, IDEXX LABORATORIES INC ORDSHS stock price is RUB 4,010.00, with a previous close of RUB 4,750.00. IDEXX LABORATORIES INC ORDSHS lost -RUB 740.00 in the last trading session, representing a -15.58% loss.

What is IDEXX LABORATORIES INC ORDSHS (IDXX-RM) current market capitalization?

IDEXX LABORATORIES INC ORDSHS market cap is approximately 52.91 billion.

What is IDEXX LABORATORIES INC ORDSHS (IDXX-RM) Earnings Per Share (EPS)?

The trailing EPS is RUB 1,034.18, and the forward EPS is RUB 16.73.

What is IDEXX LABORATORIES INC ORDSHS (IDXX-RM) Price-to-Earnings (P/E) ratio?

IDEXX LABORATORIES INC ORDSHS current P/E ratio is 0.65, with a forward P/E of 40.14.

What is IDEXX LABORATORIES INC ORDSHS (IDXX-RM) EBITDA?

IDEXX LABORATORIES INC ORDSHS EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 36.87 billion.

Does IDEXX LABORATORIES INC ORDSHS (IDXX-RM) pay dividends?

No. IDEXX LABORATORIES INC ORDSHS does not pay a dividend.

How did IDEXX LABORATORIES INC ORDSHS (IDXX-RM) perform in its most recent earnings report?

In the last report (June 30, 2026), IDEXX LABORATORIES INC ORDSHS posted an EPS surprise of 8.1% and a revenue surprise of 7,876.41%.

When is IDEXX LABORATORIES INC ORDSHS (IDXX-RM) next earnings report?

IDEXX LABORATORIES INC ORDSHS is expected to release its next earnings report on September 30, 2026.

What is IDEXX LABORATORIES INC ORDSHS (IDXX-RM) beta (volatility) score?

IDEXX LABORATORIES INC ORDSHS has a beta of 0.307, indicating lower volatility than the overall market.